Mindera Health announces the appointment of Kamal Adawi as Chief Financial Officer, effective August 14th, 2024. San Diego, CA, Aug. 12, 2024 (GLOBE NEWSWIRE) — Ron Rocca, President and CEO of Mindera Health, said, “We’re very pleased to add Kamal to the executive team. I am thrilled to work with Kamal again as he will […]
Mindera Health Announces Appointment of Kamal Adawi as Chief Financial Officer Read More »
In the face of a growing diabetes crisis, Dr. Gary Rothenberg, Director of Medical Affairs at Podimetrics, and Dr. Rachel Albright, DPM, MPH, podiatrist and researcher at Stamford Health, explore the urgent need for proactive diabetes prevention strategies within the healthcare system. This article highlights the shift from reactive treatment to collaborative care, emphasizing the
Discover how Koya Medical’s Dayspring® demonstrated superior efficacy and patient satisfaction in treating lower extremity lymphedema compared to pneumatic devices, as published in the Journal of Vascular Surgery.
In this episode of Becker’s Healthcare Podcast, Jon Bloom, CEO and co-founder of Podimetrics, shares how technology is transforming diabetes care. He highlights the vital role of patient engagement and adherence, the challenges of managing diabetes in underserved populations, and Podimetrics’ innovative solutions to improve outcomes for patients, payers, and providers.
Podimetrics’ survey of 1,001 Medicaid beneficiaries with type 2 diabetes reveals that 65% face chronic behavioral health challenges, impacting their diabetes care. Depression and anxiety disrupt medication adherence and more. Findings highlight the urgent need for integrated mental and physical health support and demand for innovative tools.
David G. Armstrong, DPM, MD, PhD; Gary M. Rothenberg, DPM, CDCES, CWS DISCLOSURES | October 18, 2024 What if teams of specialists from primary care, podiatry, endocrinology, infectious disease, vascular surgery, behavioral health, and other disciplines as needed routinely met as a “limb preservation board” or a “high-risk limb board” to discuss their shared patients, identify risks,
Can Diabetes Care Teams Improve Patient Outcomes and Value? Read More »
Koya Medical presented two clinical studies at AVLS showcasing improvements in lymphedema and venous disease outcomes with Dayspring active compression.
Koya Medical Presents Clinical Studies on Dayspring at AVLS Read More »
Koya Medical announces positive interim results from randomized controlled study of Dayspring active compression treatment for lymphedema and venous disease.
Positive Interim Results for Dayspring Lymphedema Treatment Read More »
Eirion to Present Update on Its Neuromodulator Product Candidates at The Medical Aesthetic Injectable Summit 2024October 1, 2024 – Woburn, MA – Eirion Therapeutics Inc., a biopharmaceutical company focused on developing innovative aesthetic prescription product offerings, announced today that successful results had been achieved in its Phase 1 – 2 clinical trial for the treatment of